» Articles » PMID: 38256333

Can MDCT Enhancement Patterns Be Helpful in Differentiating Secretory from Non-Functional Adrenal Adenoma?

Overview
Publisher MDPI
Specialty General Medicine
Date 2024 Jan 23
PMID 38256333
Authors
Affiliations
Soon will be listed here.
Abstract

Primary adrenal tumors (AT) are a heterogeneous group of neoplasms due to their functional heterogeneity, which results in the diverse clinical presentation of these tumors. The purpose of this study was to examine cross-sectional imaging characteristics using multi-detector computed tomography (MDCT) to provide insight into the lesion characterization and functional status of these tumors. The radionuclide imaging using Technetium-99m radiolabeled hydrazinonicotinylacid-d-phenylalanyl-tyrosine3-octreotide (Tc-HYNIC-TOC), was also used in the diagnostic evaluation of these tumors. : This cross-sectional study included 50 patients with confirmed diagnoses of AT (21 hormone-secreting and 29 non-functional) at the University Clinical Center, Kragujevac, Serbia, during the 2019-2022 year period. The morphological and dynamic characteristics using MDCT were performed, using qualitative, semi-quantitative, and quantitative analysis. Absolute washout (APW) and relative washout (RPW) values were also calculated. A semi-quantitative analysis of all visual findings with Tc-HYNIC-TOC was performed to compare the tumor to non-tumor tracer uptake. : A statistically significant difference was found in the MDCT values in the native phase ( < 0.05), the venous phase ( < 0.05), and the delayed phase ( < 0.001) to detect the existence of adrenal tumors. Most of these functional adrenocortical lesions (n = 44) can be differentiated using the delayed phase ( < 0.05), absolute percentage washout (APW) ( < 0.05), and relative percentage washout (RPW) ( < 0.001). Furthermore, Tc-HYNIC-TOC could have a high diagnostic yield to detect adrenal tumor existence ( < 0.001). There is a positive correlation between radionuclide imaging scan and APW to detect all AT ( < 0.01) and adrenocortical adenomas as well ( < 0.01). The results can be very helpful in a diagnostic algorithm to quickly and precisely diagnose the expansive processes of the adrenal glands, as well as to learn about the advantages and limitations of the mentioned imaging modalities.

References
1.
Platzek I, Sieron D, Plodeck V, Borkowetz A, Laniado M, Hoffmann R . Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis. Eur Radiol. 2018; 29(2):806-817. DOI: 10.1007/s00330-018-5626-5. View

2.
Lee J, Kim M, Ko S, Koh J, Kim B, Kim S . Clinical Guidelines for the Management of Adrenal Incidentaloma. Endocrinol Metab (Seoul). 2017; 32(2):200-218. PMC: 5503865. DOI: 10.3803/EnM.2017.32.2.200. View

3.
An Y, Yang G, Lin B, Zhang N, Hou H, Zhu F . Differentiation of lipid-poor adenoma from pheochromocytoma on biphasic contrast-enhanced CT. Abdom Radiol (NY). 2021; 46(9):4353-4361. DOI: 10.1007/s00261-021-03121-9. View

4.
Chambre C, McMurray E, Baudry C, Lataud M, Guignat L, Gaujoux S . The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas. Eur J Endocrinol. 2015; 173(3):325-32. DOI: 10.1530/EJE-15-0036. View

5.
Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E . Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014; 2(5):396-405. DOI: 10.1016/S2213-8587(13)70211-0. View